BioElectronics selects distributor for the Middle East
This article was originally published in Clinica
Dermal patch delivery system developer BioElectronics has secured a sales pathway to the Middle East for its drug-free, anti-inflammatory products. Dr Abdulkader Al-Mehyar Moh’d Basheer Halawy has become the firm’s sales agent based in Riyadh, Saudi Arabia. According to the company’s CEO Andrew Whelan, there is a strong demand for drug-free medical products in the region – the company claims that the new sales programme in the Middle East was launched with orders for 20,000 units. The Frederick, Maryland-based firm develops the ActiPatch and RecoveryRx wafer-thin patches, which contain embedded microchip and battery technology that delivers pulsed electromagnetic energy for pain relief therapy.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals